Delivery Order SPE2DB22D2214-SPE2DB24FS5PN

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,121.71 firm-fixed-price delivery order is for OLUMIANT 2 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 15, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Olumiant 4 mg tablets. The contract has a ceiling value of $13,507.38 and a completion date of May 7, 2024. It is a firm fixed-price contract, without a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award, valued at $21,756.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OLUMIANT 2 MG TABLET 30S, a prescription medication, to support federal healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division (Vendor ID: TGxsdkVQRGhOYUpNR001SFhYREdNdz09) is for the delivery of OLUMIANT 4 MG TABLET 30S (Contract ID: SPE2DX15D3005|SPE2DX24F3RVT) to the Defense Logistics Agency (DLA) Troop Support Medical. The $20,505.73 firm fixed-price delivery order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which serves as the primary vehicle for the company to provide a wide...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, the prime contractor, a firm fixed price delivery order contract valued at $3,549.10 to provide OLUMIANT 2 MG TABLET 30S to support military treatment programs and facilities. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,100.83 delivery order is for the supply of 4565089731 - OLUMIANT 2 MG TABLET 30S, a prescription medication. The contract is a Firm Fixed Price arrangement with a Pricing Type of Firm Fixed Price. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, has been awarded a $30,322.72 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to supply OLUMIANT 4 MG TABLET 30S, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $25,063.84, is a delivery order for the supply of 4565879072 OLUMIANT 4 MG TABLET 30S, a prescription medication. The contract has a firm fixed price pricing type and a completion date of September 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,003.93 firm fixed-price delivery order is for the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,860.39 firm fixed-price delivery order covers the supply of OLUMIANT 2 MG TABLET 30S, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB24FS5PN
    Delivery Order

This federal contract award is for the delivery of OLUMIANT 4 MG TABLET 30S to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, through its Corporate Office division. The contract is a Delivery Order with a Firm Fixed Price of $36,186.15 and a completion date of July 1, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/27/24, 9:12 AM